The cannabis industry is reducing its lobbying efforts in Washington due to financial difficulties stemming from the ongoing federal illegality of marijuana. Major companies like Curaleaf Holdings and Columbia Care have cut their lobbying budgets by 40% and disbanded their lobbying teams respectively. The lack of access to tax breaks, business loans, and bank accounts has exacerbated these issues. The U.S. Cannabis Council has emerged as a new coalition aiming to unify the industry's lobbying efforts.